Proven clinical technologies are combined with actionable intelligence to improve patient care by CAREFUSION.
The company’s infection prevention mission is to deliver clinically differentiated, evidence-based products and services that support the global effort to reduce HAIs. ChloraPrep is one of its products and is believed to be the only 2% chlorhexidine based product licensed for cutaneous antisepsis prior to medical and surgical invasive procedures which allows healthcare professionals to comply with evidence-based guidelines and recognised best practice for the prevention of hospital acquired infections.
